Nipro newsletter April 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

DDL 2026
Merxin March 2026
Terumo 05/01
Nipro April 2026
SAE Media – Pre-filled syringes West Coast 19/11/25
Volume 15 Issue 4

Print Quality Control Throughout the Production Process

IPI speaks with Dr. Andre Schwarz of EyeC GmbH about how Pharmaceuticals and medicaldevices require flawless printing of essential information Q: EyeC is the only...
Continue Reading →
Volume 15 Issue 4

Ophthalmic Drug Delivery for Patients

IPI speaks with Yuki Takeuchi on requirements and trends in ophthalmic drug delivery, and Terumo's solutions in the segment focusing on their primary container platf...
Continue Reading →
Volume 15 Issue 4

The Trial Master File (TMF)

IPI speaks with Aaron Grant, VP of Solutions Consulting at Phlexglobal, (a PharmaLex Company)on how managing the TMF requires following best practice and taking adva...
Continue Reading →
Volume 15 Issue 4

A Look Back: The Life Sciences Industry in 2023, and a View for 2024

The breakneck pace of digital transformation spurred by COVID-19 has continued to reshape the life sciences landscape in 2023. Rather than being defined by a single ...
Continue Reading →
Volume 15 Issue 4

Affiliates Want a Substantially Increased Role in Transforming Global RIM, Finds a Major New Global Study

New research has confirmed that in[1]country Life Sciences company affiliates feel unrepresented in the pursuit of streamlined regulatory information management on a...
Continue Reading →
Volume 15 Issue 4

What is the Right Validation Model? Practical Considerations and Applications

It is now widely accepted that validation in the life sciences industry follows a lifecycle model.1,2 What is not always clear is the specific model – or models – to...
Continue Reading →
Volume 15 Issue 4

Reliable Real-world Data & Proactive Signal Detection

The Revolution Pharmacovigilance is Crying Out for Signal detection in real-world drug monitoring has barely changed in 70 years, since the practice was first int...
Continue Reading →
Volume 15 Issue 4

Ensuring a Robust Strategy to Navigate the Development of Challenging APIs

Small molecules as therapeutic agents have played a significant role in the improvement of human health and wellbeing since the discovery and commercialisation of mo...
Continue Reading →
Volume 15 Issue 4

Why Pharmaceutical Drug Research Needs to Switch Focus

My father had Alzheimer’s. As a journalist and editor, he’d worked with words all his life and had always been impeccably correct about his grammar. But soon after h...
Continue Reading →
Volume 15 Issue 4

Promising Platforms

How novel processing platforms incorporating new technologies can help to accelerate the development of cell and gene therapy processing, overcoming key industry cha...
Continue Reading →
SMI London
Biopharma group march 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025